Immediate Impact
1 by Nobel laureates 3 from Science/Nature 67 standout
Citing Papers
Expanding chemistry through in vitro and in vivo biocatalysis
2024 StandoutNature
Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
Works of Rolf Jautelat being referenced
Abstract 1739: Preclinical profile of BAY 1163877 - a selective pan-FGFR inhibitor in phase 1 clinical trial
2014
The Lab Oddity Prevails: Discovery of Pan‐CDK Inhibitor (R)‐S‐Cyclopropyl‐S‐(4‐{[4‐{[(1R,2R)‐2‐hydroxy‐1‐methylpropyl]oxy}‐5‐(trifluoromethyl)pyrimidin‐2‐yl]amino}phenyl)sulfoximide (BAY 1000394) for the Treatment of Cancer
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rolf Jautelat | 330 | 249 | 61 | 79 | 21 | 536 | |
| Edward M. Suh | 306 | 285 | 73 | 92 | 21 | 644 | |
| Sudhakar Manda | 212 | 255 | 72 | 82 | 11 | 481 | |
| Tomohiro Matsushima | 272 | 228 | 128 | 53 | 21 | 586 | |
| James E. Ray | 323 | 271 | 81 | 38 | 19 | 566 | |
| Boris M. Seletsky | 285 | 220 | 159 | 115 | 16 | 563 | |
| Martin Hentemann | 281 | 206 | 82 | 40 | 17 | 539 | |
| João F. S. Carvalho | 178 | 283 | 54 | 44 | 12 | 513 | |
| Alessia Lopergolo | 199 | 367 | 114 | 50 | 15 | 625 | |
| Thomas Brumby | 426 | 136 | 39 | 31 | 18 | 506 | |
| Danuta Zatorska | 268 | 317 | 69 | 25 | 12 | 617 |
All Works
Loading papers...